Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ovarian Neoplasms × atezolizumab × Clear all

Phase

Status

Completed 10 Active not recruiting 3 Recruiting 2 Withdrawn 1 Unknown 1 Terminated 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 15 Melanoma 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Breast Neoplasms 4 Head and Neck Neoplasms 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Mesothelioma, Malignant 2 Gastrointestinal Neoplasms 2 Carcinoma, Merkel Cell 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Small Cell Lung Cancer Recurrent 1 Safety Issues 1 Recurrent Liver Cancer After Liver Transplantation 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1

Interventions

Carboplatin 35 Paclitaxel 34 Bevacizumab 13 olaparib 12 niraparib 11 apatinib 11 Cisplatin 10 liposomal doxorubicin 9 Gemcitabine 9 Cyclophosphamide 8 fludarabine 7 Hyperthermic Intraperitoneal Chemotherapy 7 Etoposide 7 pembrolizumab 6 Topotecan 5 Drug Therapy 5 fluzoparib 4 anlotinib 4 Surveys and Questionnaires 4 Ifosfamide 4 Doxorubicin 4 Docetaxel 4 Albumin-Bound Paclitaxel 4 oregovomab 3 Taxes 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Cytoreduction Surgical Procedures 3 Amplified Fragment Length Polymorphism Analysis 3 1-dodecylpyridoxal 3 pazopanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03363867 2023-08-07

BEACON

Peter MacCallum Cancer Centre, Australia

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡